GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC)

Historical Holders from Q1 2014 to Q2 2025

Symbol: GLYC
Type / Class: Equity / Common Stock, par value $0.001 per share
All holders as of 30 Jun 2025: Q2 2025
Total 13F shares, excl. options: 0
Holdings value: $0
Number of holders: 0
Number of sells: -31
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Weinstein Benjamin	0.1%		$12,000		50,000		Weinstein Benjamin	30 Oct 2024

Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q2	0	$0	-$6,455,728	$0	$0		0
2025 Q1	30,740,623	$6,455,829	+$54,630	$4,368	$16,989	$0.2100	32
2024 Q4	30,349,512	$7,556,907	+$3,360,077	$349	$12,699	$0.2490	38
2024 Q3	17,787,810	$3,003,325	-$2,735,557	$0	$0	$0.1690	34
2024 Q2	25,554,956	$7,195,771	-$32,011,613	$43,169	$545,643	$0.2816	33
2024 Q1	36,846,967	$110,538,682	+$5,529,283	$1,909,200	$2,907,600	$3.00	67
2023 Q4	35,101,664	$82,836,847	+$988,015	$65,844	$170,156	$2.36	57
2023 Q3	34,726,628	$52,083,531	-$1,381,303	$31,050	$347,250	$1.50	48
2023 Q2	35,591,469	$61,923,460	-$2,358,181	$92,394	$211,758	$1.74	53
2023 Q1	36,991,329	$46,608,472	+$10,727,439	$588,293	$566,418	$1.26	52
2022 Q4	27,502,473	$83,329,939	+$4,920,713	$1,818	$492,984	$3.03	47
2022 Q3	25,944,512	$14,312,754	-$391,819		$0	$0.5517	30
2022 Q2	26,459,719	$15,820,424	-$1,284,297		$37,000	$0.5980	32
2022 Q1	27,408,509	$31,731,208	-$2,635,938	$0	$127,000	$1.14	40
2021 Q4	29,684,722	$42,741,693	-$358,246	$415,000	$254,000	$1.44	43
2021 Q3	29,651,355	$64,933,187	-$3,251,935	$576,000	$678,000	$2.19	45
2021 Q2	31,256,137	$72,514,257	-$13,820,623	$813,000	$945,000	$2.32	56
2021 Q1	36,665,910	$110,363,364	-$9,181,296	$745,000	$584,000	$3.01	76
2020 Q4	38,695,728	$145,493,534	+$615,055	$611,000	$139,000	$3.76	88
2020 Q3	42,483,527	$130,428,270	-$2,920,468	$204,000	$2,819,000	$3.07	79
2020 Q2	40,376,179	$151,810,870	+$3,564,383	$243,000	$41,000	$3.76	85
2020 Q1	39,657,261	$90,418,867	-$5,181,980			$2.28	73
2019 Q4	41,560,365	$219,855,933	-$178,331		$0	$5.29	78
2019 Q3	41,656,066	$179,538,502	-$88,546,600	$1,000	$56,000	$4.31	73
2019 Q2	44,913,780	$535,350,693	+$51,732,507	$1,453,000	$0	$11.92	78
2019 Q1	45,466,239	$566,540,993	+$4,511,593	$194,000	$373,000	$12.46	76
2018 Q4	45,207,365	$428,101,787	-$17,655,322	$0	$0	$9.47	81
2018 Q3	46,376,919	$667,832,541	-$2,739,089	$683,000	$1,002,000	$14.40	85
2018 Q2	46,332,380	$747,337,222	+$44,634,859	$994,000	$1,523,000	$16.13	84
2018 Q1	43,532,023	$706,521,000	+$188,051,140	$1,167,000	$5,372,000	$16.23	81
2017 Q4	31,891,452	$535,458,000	+$35,628,339	$2,221,000	$761,000	$16.79	80
2017 Q3	29,749,543	$416,194,007	-$2,748,905	$192,000	$0	$13.99	55
2017 Q2	30,307,949	$338,229,804	+$128,038,717	$1,115,000	$336,000	$11.16	69
2017 Q1	19,126,126	$103,859,000	+$4,637,141			$5.43	43
2016 Q4	18,933,281	$115,491,000	+$2,927,862			$6.10	49
2016 Q3	18,405,944	$131,599,591	-$753,008			$7.15	47
2016 Q2	18,503,534	$134,519,808	+$32,285,760			$7.27	49
2016 Q1	14,058,954	$83,773,000	+$1,183,473			$5.96	28
2015 Q4	13,867,564	$79,311,000	+$271,944			$5.72	28
2015 Q3	13,820,640	$77,390,000	+$296,162			$5.60	30
2015 Q2	13,766,784	$109,429,000	+$143,657			$7.95	29
2015 Q1	13,745,019	$114,358,000	-$1,038,096			$8.32	28
2014 Q4	13,897,431	$100,058,000	+$1,909,768			$7.20	26
2014 Q3	13,397,783	$92,978,298	-$1,099,194			$6.94	24
2014 Q2	13,516,993	$113,943,965	-$8,397,057			$8.43	30
2014 Q1	14,070,204	$229,767,000	+$229,767,000			$16.33	36